Popular Trials
Combined gastric mucosal ablation with endoscopic sleeve gastroplasty for Obesity
Recruiting1 award6 criteria
Cary, North Carolina
The purpose of this study is to construct a multi-site, prospective registry to evaluate the clinical outcomes of patients who have undergone combined gastric mucosal ablation with endoscopic sleeve gastroplasty at True You Weight Loss.
Cohort 3: Other-exposed participants with narcolepsy or OSA for Narcolepsy
Recruiting1 award5 criteria
Morrisville, North Carolina
The SUNOSI (solriamfetol) Pregnancy Registry is a prospective, multi-country, observational study to evaluate the safety of solriamfetol exposure during pregnancy in women with a diagnosis of narcolepsy or obstructive sleep apnea (OSA).
Full Analysis set for Dry Eye Syndrome
Recruiting1 award6 criteria
Raleigh, North Carolina
Primary Objective - To assess the proportion of patients with Sjögren's dry eye who demonstrate impaired corneal sensitivity. Secondary Objectives To assess corneal sensitivity via Cochet-Bonnet esthesiometer. To assess tear secretion via Schirmer I test. To assess OPAS questionnaire results.
Popular Filters
Phase 3 Trials
Anti-epileptic Drug
BHV-7000 for Epilepsy
Recruiting0 awardsPhase 2 & 3
Charlotte, North Carolina
This trial aims to find out if BHV-7000 can effectively treat a type of epilepsy that causes seizures with loss of consciousness. The study also includes a phase where participants can continue treatment in an
Trials With No Placebo
Behavioral Intervention
EMG-Controlled Prosthetic Ankle for Below Knee Amputation
Recruiting1 award4 criteria
Raleigh, North Carolina
"This trial aims to study the effects of training amputees to use direct electromyographic (dEMG) control of a powered prosthetic ankle. The study will focus on whether this training can
Behavioural Intervention
Alliance180 Program for Trauma
Recruiting1 award1 criteria
Chapel Hill, North Carolina
This trial aims to study how the Alliance180 Program affects the physical and mental well-being of US Veterans, First Responders, and Front Line Healthcare Workers. Participants will complete surveys before and after the program
Retrospective arm for Heart Failure
Recruiting1 award2 criteria
Raleigh, North Carolina
The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulatory hemodynamics monitoring and HF (Heart Failure) therapies. The data collected will be used for retrospective studies, quality improvement, identifying research cohorts, and member-initiated research.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.